Funding for this research was provided by:
Oncosuisse (KLS-3814-02-2016)
Article History
Received: 14 May 2022
Revised: 11 July 2022
Accepted: 15 July 2022
First Online: 29 July 2022
Competing interests
: CQR and MS report no conflicts of interest. MW has received research grants from Apogenix, Merck, Sharp & Dohme, Merck (EMD), Philogen and Quercis, and honoraria for lectures or advisory board participation or consulting from Adastra, Bayer, Bristol Meyer Squibb, Medac, Merck, Sharp & Dohme, Merck (EMD), Nerviano Medical Sciences, Novartis, Orbus, and Philogen.